OdysseaBio
OdysseaBio is a women-owned strategic partnership dedicated to transforming complex science into trusted narratives that reduce risk and drive confident decisions across the innovation journey. We partner with biotech, pharma, advocacy, and health decision-makers to ensure clarity, alignment, and impact at every stage.
Co-founded by two PhD scientists, OdysseaBio bridges science, business, and healthcare to craft narratives that are scientifically rigorous, strategically clear, and credible to the audiences who matter most. More than translation, we deliver transformation—helping leadership teams achieve alignment, build lasting trust, and ensure their innovation is understood, trusted, and positioned for maximum impact with investors, decision-makers, and clinical communities.
Media & Communications, Professional Services, Strategic Consulting
- Animal Modeling
- Autoimmune Diseases
- Biologic Medicines
- Cardiovascular Disease
- Cellular Medicine
- Diabetes
- Gene Therapy
- Immune Therapy
- Inflammatory Diseases
- Metabolic Diseases
- Molecular Diagnostics
- mRNA
- Neurological Diseases
- Neurophysiology
- Oncology
- Teaching and Training
- Therapeutics
- Women’s Health
Grants & Funding , Innovation to Market, Media & Communications , Professional Services , Strategic Consulting , Strategic Growth & Investment, Teach & Training
OdysseaBio delivers high-impact strategic communications and narrative development tailored to the needs of biotech, pharma, research institutes, healthcare decision-makers, and patient advocacy groups. We partner directly with leadership teams to transform complex science into compelling, credible messaging that aligns stakeholders and drives confident decisions. Whether through focused advisory sessions or comprehensive, multi-phase projects, we provide evidence-based narratives that strengthen trust and accelerate milestones from discovery and early research to commercialization and post-market engagement.
Pre-Seed, Private Company, Public Company, Seed, Series A, Series B, Series C, Other
We are working On:
We partner with leadership teams to advance their innovation journey—from discovery and early research through to commercialization and beyond. We shape strategic narratives that strengthen investor pitches, grant proposals, stakeholder alignment, and market readiness.
We are looking For:
We welcome opportunities to collaborate with biotech and pharma leaders, tech-transfer spin-offs, research institutions, advocacy groups, and healthcare or government organizations seeking strategic communication and narrative support across the innovation lifecycle.
Member Profile
Media & Communications, Professional Services, Strategic Consulting
OdysseaBio
- Website www.odysseabio.com/
- Email innovate@odysseabio.com
- Address
Quebec, Canada - Leadership Contact
Deborah Maret, PhD and Georghia Michael, PhD